Search results
Results from the WOW.Com Content Network
Mass concentration, g/(100 ml) at 15.56 °C Density relative to 4 °C water Density at 20 °C relative to 20 °C water Density at 25 °C relative to 25 °C water Freezing temperature, °C 10 °C 20 °C 25 °C 30 °C
2 He helium-4; Hoffer et al. 0.19085 g/cm 3 (from 20.9730 cm 3 /mole; hcp crystal melting to He-II superfluid at 0 K, 25.00 atm) : 0.19083 g/cm 3 (from 20.9749 cm 3 /mole; at local min. density, hcp melting to He-II: 0.884 K, 25.00 atm)
Cyclohexanol is produced by the oxidation of cyclohexane in air, typically using cobalt catalysts: [5]. 2 C 6 H 12 + O 2 → 2 C 6 H 11 OH. This process coforms cyclohexanone, and this mixture ("KA oil" for ketone-alcohol oil) is the main feedstock for the production of adipic acid.
Ethenone is produced by thermal dehydration of acetic acid at 700–750 °C in the presence of triethyl phosphate as a catalyst: [7] [8]. CH 3 CO 2 H → CH 2 =C=O + H 2 O. It has also been produced on a laboratory scale by the thermolysis of acetone at 600–700 °C.
Cyclohexanone is produced by the oxidation of cyclohexane in air, typically using cobalt catalysts: [11]. C 6 H 12 + O 2 → (CH 2) 5 CO + H 2 O. This process forms cyclohexanol as a by-product, and this mixture, called "KA Oil" for ketone-alcohol oil, is the main feedstock for the production of adipic acid.
114,19 g·mol −1 Appearance colorless liquid with a smell of alcohol [1] Density: 0,9339 g·cm −3 [2] Melting point: 19 °C (66 °F) [1] Boiling point:
The copolymer tends to resist degradation, e.g. to acetaldehyde. The copolymer with PET is known as glycol-modified polyethylene terephthalate, PETG. PETG is used in many fields, including electronics, automobiles, barrier, and medical, etc. CHDM is a raw material for the production of 1,4-cyclohexanedimethanol diglycidyl ether, an epoxy ...
1-Ethynylcyclohexanol (ECX) is an alkynyl alcohol derivative which is both a synthetic precursor to, and an active metabolite of the tranquilizer ethinamate, and has similar sedative, anticonvulsant and muscle relaxant effects. It has been sold as a designer drug, first being identified in the UK in March 2012. [1] [2] [3] [4]